These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 12943819

  • 1. Pharmacokinetics and tissue distribution of intraperitoneal docetaxel with different carrier solutions.
    Mohamed F, Stuart OA, Sugarbaker PH.
    J Surg Res; 2003 Jul; 113(1):114-20. PubMed ID: 12943819
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F, Marchettini P, Stuart OA, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [Abstract] [Full Text] [Related]

  • 3. A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery.
    Mohamed F, Marchettini P, Stuart OA, Yoo D, Sugarbaker PH.
    Eur J Surg Oncol; 2003 Apr; 29(3):261-5. PubMed ID: 12657237
    [Abstract] [Full Text] [Related]

  • 4. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy.
    Pestieau SR, Schnake KJ, Stuart OA, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):269-76. PubMed ID: 11320672
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.
    Wei ZG, Li GX, Huang XC, Zhen L, Yu J, Deng HJ, Qing SH, Zhang C.
    World J Gastroenterol; 2008 Apr 14; 14(14):2179-86. PubMed ID: 18407591
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer.
    de Bree E, Rosing H, Beijnen JH, Romanos J, Michalakis J, Georgoulias V, Tsiftsis DD.
    Anticancer Drugs; 2003 Feb 14; 14(2):103-10. PubMed ID: 12569296
    [Abstract] [Full Text] [Related]

  • 9. Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats.
    Kamijo Y, Ito C, Nomura M, Sai Y, Miyamoto K.
    Cancer Lett; 2010 Jan 28; 287(2):182-6. PubMed ID: 19608331
    [Abstract] [Full Text] [Related]

  • 10. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
    Morgan RJ, Doroshow JH, Synold T, Lim D, Shibata S, Margolin K, Schwarz R, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Lin P, Paz B, Chu D, Frankel P, Stalter S.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5896-901. PubMed ID: 14676112
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies.
    Pestieau SR, Belliveau JF, Griffin H, Stuart OA, Sugarbaker PH.
    J Surg Oncol; 2001 Feb 01; 76(2):106-14. PubMed ID: 11223836
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.
    Shimada T, Nomura M, Yokogawa K, Endo Y, Sasaki T, Miyamoto K, Yonemura Y.
    J Pharm Pharmacol; 2005 Feb 01; 57(2):177-81. PubMed ID: 15720780
    [Abstract] [Full Text] [Related]

  • 13. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR, Stuart OA, Sugarbaker PH.
    Eur J Surg Oncol; 2000 Nov 01; 26(7):696-700. PubMed ID: 11078617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration.
    Soma D, Kitayama J, Ishigami H, Kaisaki S, Nagawa H.
    J Surg Res; 2009 Jul 01; 155(1):142-6. PubMed ID: 19328496
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic Properties of the Carrier Solutions for Hyperthermic Intraperitoneal Chemotherapy: Comparative Analyses Between Water and Lipid Carrier Solutions in the Rat Model.
    Park EJ, Ahn J, Gwak SW, Park KS, Baik SH, Hwang SJ.
    Ann Surg Oncol; 2018 Oct 01; 25(11):3185-3192. PubMed ID: 30027459
    [Abstract] [Full Text] [Related]

  • 18. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E, Rosing H, Filis D, Romanos J, Melisssourgaki M, Daskalakis M, Pilatou M, Sanidas E, Taflampas P, Kalbakis K, Beijnen JH, Tsiftsis DD.
    Ann Surg Oncol; 2008 Apr 01; 15(4):1183-92. PubMed ID: 18239973
    [Abstract] [Full Text] [Related]

  • 19. Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.
    Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL.
    Pharm Res; 2007 Sep 01; 24(9):1691-701. PubMed ID: 17447121
    [Abstract] [Full Text] [Related]

  • 20. Pharmaceutical aspects of docetaxel.
    Kraynak MA.
    Am J Health Syst Pharm; 1997 Dec 15; 54(24 Suppl 2):S7-10. PubMed ID: 9435926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.